About Us

Our goal is to help clinicians select the right therapy, for
the right patient, at the right time

Kinomica has developed KScan®, a phosphoproteomic
diagnostic platform to help better realize the full potential
of Precision Medicine.

We are a response-to-treatment company
focused on questions such as:

Of the drugs currently approved to treat a disease, which one is best for a particular patient?

For patients that don’t respond to treatment or relapse shortly afterwards, are there drugs approved for other diseases that may be beneficial?

How can phosphoproteomics help to
develop better drugs?


Phosphoproteomics Looks at How Phosphorylation Regulates Protein Function

Importantly it provides insight on what proteins and signaling pathways are actually activated. Key information for developing next-generation diagnostics and for finding new drug targets.